Rtw Investments as of Sept. 30, 2016
Portfolio Holdings for Rtw Investments
Rtw Investments holds 36 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alnylam Pharmaceuticals (ALNY) | 19.4 | $64M | 948k | 67.78 | |
Avexis | 10.3 | $34M | 826k | 41.21 | |
Agenus | 9.0 | $30M | 4.1M | 7.18 | |
La Jolla Pharmaceuticl Com Par | 8.4 | $28M | 1.2M | 23.79 | |
BioCryst Pharmaceuticals (BCRX) | 5.6 | $19M | 4.2M | 4.41 | |
Incyte Corporation (INCY) | 5.5 | $18M | 191k | 94.29 | |
Achillion Pharmaceuticals | 5.4 | $18M | 2.2M | 8.10 | |
Dicerna Pharmaceuticals | 3.6 | $12M | 2.0M | 5.88 | |
Bristol Myers Squibb (BMY) | 3.4 | $11M | 210k | 53.92 | |
SPDR Gold Trust (GLD) | 3.1 | $10M | 83k | 125.64 | |
Atara Biotherapeutics | 3.0 | $9.8M | 458k | 21.39 | |
Arrowhead Pharmaceuticals (ARWR) | 2.5 | $8.2M | 1.1M | 7.35 | |
Heron Therapeutics (HRTX) | 2.0 | $6.7M | 387k | 17.23 | |
Viveve Med | 1.8 | $6.1M | 839k | 7.22 | |
Bluebird Bio (BLUE) | 1.8 | $5.9M | 88k | 67.78 | |
Corium Intl | 1.8 | $5.9M | 1.0M | 5.63 | |
Invuity | 1.6 | $5.4M | 393k | 13.72 | |
Celldex Therapeutics | 1.5 | $5.0M | 1.2M | 4.04 | |
Medicines Company | 1.4 | $4.6M | 123k | 37.74 | |
Omeros Corporation (OMER) | 1.3 | $4.3M | 383k | 11.16 | |
Tactile Systems Technology, In (TCMD) | 1.3 | $4.3M | 228k | 18.70 | |
Barclays Bank Plc etn djubscoffe38 (JJOFF) | 1.2 | $4.0M | 181k | 22.26 | |
Regenxbio Inc equity us cm (RGNX) | 1.0 | $3.3M | 239k | 14.01 | |
Oxford Immunotec Global | 0.9 | $3.0M | 236k | 12.56 | |
Five Prime Therapeutics | 0.7 | $2.3M | 44k | 52.49 | |
Global Blood Therapeutics In | 0.7 | $2.2M | 96k | 23.05 | |
Masimo Corporation (MASI) | 0.5 | $1.5M | 26k | 59.50 | |
Novavax | 0.3 | $996k | 4.8k | 208.06 | |
Mirati Therapeutics | 0.3 | $854k | 129k | 6.61 | |
Sensus Healthcare (SRTS) | 0.2 | $773k | 126k | 6.15 | |
Biopharmx | 0.1 | $392k | 701k | 0.56 | |
Natera (NTRA) | 0.1 | $352k | 32k | 11.11 | |
Audentes Therapeutics | 0.1 | $356k | 20k | 17.80 | |
MannKind Corporation | 0.1 | $272k | 4.4k | 62.03 | |
Nivalis Therapeutics | 0.1 | $244k | 30k | 8.13 | |
Abeona Therapeutics | 0.0 | $116k | 19k | 5.98 |